Abstract
Background: An ideal strategy for cancer treatment is the specific induction of tumor cell death, sparing normal cells. Marine sponges are rich biological reservoirs of biomolecules, especially lectins, which have attracted considerable attention due to potential biological effect on human cells. Lectins are proteins that bind specific carbohydrate signatures and some gained further interest for their capacity to bind tumor associated carbohydrates antigens and induce tumor cell apoptosis.
Objective: This study aimed to evaluate the antitumor potential of H3, a lectin, recently reported from marine sponge Haliclona caerulea on the human breast cancer cell line MCF7.
Results: H3 reduced MCF7 cell viability with an IC50 of 100 µg/ml, without a significant effect on normal cells. At 24 h, H3 induced a significant arrest in the G1 cell cycle phase. Consistently, almost 50% of the cells were in early apoptosis and showed remarkable increased expression of caspase-9 (CASP 9). H3 impaired dramatically the adhesiveness of MCF7 cells in culture. Assays conducted with Lysotracker Red probe showed increased organelle acidity, suggesting autophagic cell death, which was further supported by increased expression of microtubuleassociated protein light chain 3 (LC3) and observable conversion of LC3-I in LC3-II by western blot.
Conclusion: The apoptotic effect of H3 may be related to a balance between apoptotic and autophagic cell death, mediated by increased expression of CASP 9 and LC3-II. To the best of our knowledge this is the first report about a sponge lectin triggering both apoptosis and autophagy in MCF7 cell.
Keywords: Breast cancer, apoptosis, lectins, marine sponges, Haliclona caerulea, autophagy.
Anti-Cancer Agents in Medicinal Chemistry
Title:Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression
Volume: 18 Issue: 4
Author(s): Luiz G. do Nascimento-Neto, Maria G. Cabral, Romulo F. Carneiro, Zelia Silva, Francisco V.S. Arruda, Celso S. Nagano, Alexandra R. Fernandes, Alexandre H. Sampaio, Edson H. Teixeira*Paula A. Videira*
Affiliation:
- Laboratorio de Biotecnologia Marinha (BioMar-Lab), Departamento de Engenharia de Pesca, Universidade Federal do Ceara, Campus do Pici S/N, Bloco 871, 60.440-970, Fortaleza, Ceara,Brazil
- UCIBIO, Departamento de Ciencias da Vida, Faculdade de Ciencias e Tecnologia, Universidade NOVA de Lisboa, 2829-516, Caparica,Portugal
Keywords: Breast cancer, apoptosis, lectins, marine sponges, Haliclona caerulea, autophagy.
Abstract: Background: An ideal strategy for cancer treatment is the specific induction of tumor cell death, sparing normal cells. Marine sponges are rich biological reservoirs of biomolecules, especially lectins, which have attracted considerable attention due to potential biological effect on human cells. Lectins are proteins that bind specific carbohydrate signatures and some gained further interest for their capacity to bind tumor associated carbohydrates antigens and induce tumor cell apoptosis.
Objective: This study aimed to evaluate the antitumor potential of H3, a lectin, recently reported from marine sponge Haliclona caerulea on the human breast cancer cell line MCF7.
Results: H3 reduced MCF7 cell viability with an IC50 of 100 µg/ml, without a significant effect on normal cells. At 24 h, H3 induced a significant arrest in the G1 cell cycle phase. Consistently, almost 50% of the cells were in early apoptosis and showed remarkable increased expression of caspase-9 (CASP 9). H3 impaired dramatically the adhesiveness of MCF7 cells in culture. Assays conducted with Lysotracker Red probe showed increased organelle acidity, suggesting autophagic cell death, which was further supported by increased expression of microtubuleassociated protein light chain 3 (LC3) and observable conversion of LC3-I in LC3-II by western blot.
Conclusion: The apoptotic effect of H3 may be related to a balance between apoptotic and autophagic cell death, mediated by increased expression of CASP 9 and LC3-II. To the best of our knowledge this is the first report about a sponge lectin triggering both apoptosis and autophagy in MCF7 cell.
Export Options
About this article
Cite this article as:
do Nascimento-Neto G. Luiz , Cabral G. Maria , Carneiro F. Romulo, Silva Zelia , Arruda V.S. Francisco , Nagano S. Celso , Fernandes R. Alexandra , Sampaio H. Alexandre, Teixeira H. Edson *, Videira A. Paula *, Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (4) . https://dx.doi.org/10.2174/1871520617666171114094847
DOI https://dx.doi.org/10.2174/1871520617666171114094847 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Malignant Pleural Effusions: Review of Treatment and Our Experience
Reviews on Recent Clinical Trials Patented Herbal Formulations and their Therapeutic Applications
Recent Patents on Drug Delivery & Formulation Interaction of Macrocyclic Lactones with the Multidrug Transporters: The Bases of the Pharmacokinetics of Lipid-Like Drugs
Current Drug Metabolism Patent Review
Combinatorial Chemistry & High Throughput Screening An Integrated Platform for Bio-Analysis and Drug Delivery
Current Pharmaceutical Biotechnology “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy Energy Balance and Carcinogenesis: Underlying Pathways and Targets for Intervention
Current Cancer Drug Targets Combinatorial Approaches for the Identification of Brain Drug Delivery Targets
Current Pharmaceutical Design Breast Cancer Classification Using Discrete Wavelet Transformation and Deep Learning
Recent Advances in Computer Science and Communications Late Effects in Survivors of Childhood CNS Tumors: Review of Results From the Two Largest Survivorship Cooperative Groups
Current Cancer Therapy Reviews PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
Current Pharmaceutical Design Potential Application of Gene Therapy to X-Linked Agammaglobulinemia
Current Gene Therapy Role of Protein Tyrosine Phosphatases in Plants
Current Genomics Promises of Apoptosis-Inducing Peptides in Cancer Therapeutics
Current Pharmaceutical Biotechnology Late Life Depression: A Diagnostic and Pharmacological Review
Current Psychopharmacology Geminin as A Molecular Target for the Development of New Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Role of MicroRNA 21 in Mesenchymal Stem Cell (MSC) Differentiation: A Powerful Biomarker in MSCs Derived Cells
Current Pharmaceutical Biotechnology Targeting Interleukin (IL) 5 for Asthma and Hypereosinophilic Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Genetic Vaccination for the Active Immunotherapy of Cancer
Current Gene Therapy Synthesis and Evaluation of Novel Pyrido[1,2-b][1,2,4]triazine-2,6-dione and Pyrido[1,2-b][1,2,4]triazepine-2,7-dione Derivatives as Antioxidant Agents
Letters in Organic Chemistry